Virus-like particles as vaccine adjuvants

被引：0
作者：
Sarah C. Gilbert
机构：
[1] Wellcome Trust Centre for Human Genetics,
来源：
Molecular Biotechnology | 2001年 / 19卷
关键词：
Virus-like particle; Ty-VLP; recombinant sub-unit vaccine; CTL;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Virus-like particles (VLPs) consist of one or more viral coat proteins that assemble into particles. They can be taken up by antigen presenting cells (APC), peptides derived from them are presented on MHC class I molecules at the cell surface, and thereby prime a CD8+ T cell response, either against the particle-forming protein itself (such as Hepatitis B surface antigen) or additional peptide sequences that are produced as fusions with the particle-forming protein. This article describes the preparation of Ty-VLPs in Saccharomyces cerevisiae, a system that can easily be handled in the laboratory or scaled up for manufacture, and is safe in use.
引用
收藏
页码：169 / 177
页数：8
相关论文
共 90 条
[1]  
Schneider J.(1998)Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Nat. Med. 4 397-402
[2]  
Gilbert S. C.(2000)Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice J. Immunol. 165 2850-2858
[3]  
Blanchard T. J.(1995)Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restriced epitope presentation Eur. J. Immunol. 25 1063-1070
[4]  
Dupuis M.(1995)Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens Vaccine 13 857-865
[5]  
Denis-Mize K.(1994)Immunization with soluble hepatitis B virus sàzface protein elicits murine H-2 Class I-restricted CD8+ cytotoxic T lymphocyte resonses in vivo J. Immunol. 152 1110-1119
[6]  
Woo C.(1996)The effects of adjuvants on CTL induction by V3:Ty-virus-like-particles (V3-VLPs) in mice Vaccine 14 971-976
[7]  
Schirmbeck R.(1998)Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like aprticle, combined with zidovudine, in asymptomatic subjects AIDS 12 175-185
[8]  
Melber K.(1998)Oral immunisation with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice J. Virol. 72 1345-1353
[9]  
Reimann J.(1997)Rotavirus virus-like particles administered mucosally induce protective immunity J. Virol. 71 8707-8717
[10]  
Schirmbeck R.(1997)Specific interactions between human integrin alpha v beta 3 and chimeric hepatitis B virus core particles bearing the receptor-binding epitope of foot-and-mouth disease virus Virology 239 150-157
123456789